Spyre Therapeutics, Inc. — 4 Filings
187 4 filings on record
This page lists all 4 filings submitted to the SEC by Spyre Therapeutics, Inc. (SYRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Spyre Therapeutics, Inc. has filed 187 4 documents with the SEC since 2015. To view all SEC filings by Spyre Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001636282-26-000026 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001636282-26-000028 | Mar 3, 2026 | — |
| 4 | FORM 4 | 0001758363-26-000005 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001779990-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001636282-26-000003 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000002 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000004 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000001 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001758363-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001758363-25-000003 | Dec 3, 2025 | Dec 1, 2025 |
| 4 | FORM 4 | 0001636282-25-000106 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001636282-25-000095 | Sep 3, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001636282-25-000067 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000068 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000069 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000064 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000065 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000066 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000008 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | FORM 4 | 0001636282-25-000009 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | FORM 4 | 0001636282-25-000010 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | FORM 4 | 0001636282-25-000007 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | FORM 4 | 0001636282-25-000002 | Jan 14, 2025 | Jan 10, 2025 |
| 4 | FORM 4 | 0001636282-24-000089 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | FORM 4 | 0001636282-24-000070 | Oct 28, 2024 | Oct 25, 2024 |
| 4 | FORM 4 | 0001636282-24-000068 | Oct 1, 2024 | — |
| 4 | FORM 4 | 0001636282-24-000062 | Sep 5, 2024 | Sep 3, 2024 |
| 4 | 4 | 0000950170-24-061085 | May 16, 2024 | May 14, 2024 |
| 4 | 4 | 0000950170-24-061082 | May 16, 2024 | May 14, 2024 |
| 4 | 4 | 0000950170-24-061083 | May 16, 2024 | May 14, 2024 |
| 4 | 4 | 0000950170-24-061080 | May 16, 2024 | May 14, 2024 |
| 4 | 4 | 0000950170-24-061084 | May 16, 2024 | May 14, 2024 |
| 4 | 4 | 0000950170-24-048457 | Apr 25, 2024 | — |
| 4 | 4 | 0000950170-24-017494 | Feb 20, 2024 | Feb 15, 2024 |
| 4 | 4 | 0000950170-24-011369 | Feb 5, 2024 | Feb 1, 2024 |
| 4 | 4 | 0000950170-24-010904 | Feb 2, 2024 | Feb 1, 2024 |
| 4 | 4 | 0000950170-24-010896 | Feb 2, 2024 | Feb 1, 2024 |
| 4 | 4 | 0000950170-24-010901 | Feb 2, 2024 | Feb 1, 2024 |
| 4 | 4 | 0000950170-23-073904 | Dec 29, 2023 | — |
| 4 | 4 | 0000950170-23-072763 | Dec 22, 2023 | — |
| 4 | 4 | 0000950170-23-069455 | Dec 11, 2023 | Dec 7, 2023 |
| 4 | 4 | 0000950170-23-066399 | Nov 28, 2023 | Nov 24, 2023 |
| 4 | 4 | 0000950170-23-066131 | Nov 27, 2023 | Nov 22, 2023 |
| 4 | 4 | 0000950170-23-066143 | Nov 27, 2023 | Nov 22, 2023 |
| 4 | 4 | 0000950170-23-066146 | Nov 27, 2023 | Nov 22, 2023 |
| 4 | 4 | 0000950170-23-046396 | Sep 5, 2023 | Sep 1, 2023 |
| 4 | 4 | 0000950170-23-046384 | Sep 5, 2023 | Sep 1, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-040333 | Jun 30, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-040335 | Jun 30, 2023 | Jun 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-040338 | Jun 30, 2023 | Jun 22, 2023 |